Valuation: Repligen Corporation

Market Cap 8.03B 7.03B 6.48B 6.01B 11.42B 766B 11.58B 77.56B 30.19B 376B 30.17B 29.5B 1,304B P/E 2026 *
131x
P/E 2027 * 79.3x
Enterprise Value 7.78B 6.81B 6.27B 5.82B 11.06B 742B 11.21B 75.11B 29.23B 364B 29.21B 28.57B 1,263B EV / Sales 2026 *
9.51x
EV / Sales 2027 * 8.06x
Free-Float
94.26%
Yield 2026 *
-
Yield 2027 * -
1 day-0.66%
1 week+3.26%
Current month+3.68%
1 month+12.87%
3 months+20.96%
6 months-17.88%
Current year-13.67%
1 week 134.01
Extreme 134.01
143.16
1 month 121.2
Extreme 121.205
149.05
Current year 100.99
Extreme 100.99
175.77
1 year 100.99
Extreme 100.99
175.77
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
327.32
10 years 25.93
Extreme 25.93
327.32
Manager TitleAgeSince
Chief Executive Officer 56 01/09/2024
Director of Finance/CFO 52 25/09/2023
Chief Tech/Sci/R&D Officer - 01/08/2025
Director TitleAgeSince
Chairman 74 14/12/2011
Director/Board Member 60 12/06/2014
Director/Board Member 67 01/10/2015
Date Insider Type Main position Quantity % Market Cap.
06-25Sell

Chief Financial Officer

-733 0.0013%
05-14Free

Chairman

3,234 0.0057%
05-14Free

Director

3,234 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
-0.66%+3.26%+13.69%+0.30% 8.03B
+0.24%+3.15%-28.47%-10.79% 166B
-0.16%+2.63%-5.26%-3.50% 106B
+0.69%+6.00%-1.31%+55.34% 57.69B
-1.37%0.00%+53.74%+52.32% 53.78B
-1.61%+0.23%-10.07%-39.92% 43.56B
-1.02%+7.93% - - 36.52B
+1.59%+3.43%-12.73%-43.32% 27.49B
-2.21%+0.83%+61.48%-4.18% 25.84B
-2.25%+0.02%-8.59%-2.37% 21.27B
Average -0.50%+4.01%+6.94%+0.43% 54.68B
Weighted average by Cap. -0.55%+3.71%-3.43%+1.48%

Financials

2026 *2027 *
Net sales 818M 717M 660M 613M 1.16B 78.05B 1.18B 7.9B 3.07B 38.31B 3.07B 3.01B 133B 943M 826M 761M 706M 1.34B 89.98B 1.36B 9.11B 3.54B 44.17B 3.54B 3.46B 153B
Net income 61.09M 53.5M 49.28M 45.74M 86.86M 5.83B 88.04M 590M 230M 2.86B 229M 224M 9.92B 101M 88.61M 81.61M 75.76M 144M 9.65B 146M 977M 380M 4.74B 380M 372M 16.42B
Net Debt -254M -223M -205M -191M -362M -24.27B -367M -2.46B -956M -11.91B -955M -935M -41.3B -432M -378M -348M -323M -614M -41.19B -622M -4.17B -1.62B -20.22B -1.62B -1.59B -70.11B
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
07/07/26 US$141.46 -0.66% 660,187
02/07/26 US$142.40 +2.45% 985,760
01/07/26 US$138.99 +1.87% 1,161,912
30/06/26 US$136.44 -0.41% 1,106,310
29/06/26 US$137.00 -6.81% 1,802,598
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
142.40USD
Average target price
176.11USD
Spread / Average Target
+23.67%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock